genOway is a biotechnology company with more than 20 years of expertise in the design of preclinical models of high physiological relevance, that has developed a catalog of "off-the-shelf" models in immuno-oncology.

With its growing catalog of humanized immune checkpoint mouse models and cell lines and reconstituted mice with human immune systems, genOway offers a wide range of tools to study the mechanism of action, efficacy and safety of immunotherapies.

Founded in 1999, genOway currently operates in over 28 countries in North America, Europe and Asia, and serves clients in 380 academic institutions and 170 life science companies, including 17 of the top 20 pharmaceutical companies.

Meet The Team

Kader Thiam - plan poitrine
Emma Reungoat

Kader Thiam, PhD

Senior Vice President Discovery - Preclinical Models & Services

+33 (0)4 37 65 41 09

Emma Reungoat, PhD

Business Developer

+33 (0)6 09 06 84 52

Fabiane Sonego, PhD

Innovation Project Manager - ICP humanized models

+33 (0)4 37 65 95 96